Login / Signup
Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis.
Jaejun Lee
Ahlim Lee
Pil Soo Sung
Jeong Won Jang
Si Hyun Bae
Jong Young Choi
Seung Kew Yoon
Hyun Yang
Published in:
The Korean journal of internal medicine (2024)
Four high-genetic barrier NAs were compared, and TDF was more likely to achieve a VR after 48 weeks, while ETV provided a superior BR after 48 weeks.
Keyphrases
</>
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
genome wide
acute lymphoblastic leukemia
peritoneal dialysis
copy number
gestational age
prognostic factors
gene expression
molecular docking
patient reported outcomes
combination therapy